Rethinking Canine Osteoarthritis - 

'From Pathogenesis to Practice'
with Professor Stuart Carmichael & Renzo Di Florio 

Register Now
LEARNING OUTCOMES
SPEAKERS
ABOUT

Free Webinar | Tuesday 30th September | KRKA

Talk Summary

Join orthopaedic specialist Professor Stuart Carmichael and KRKA’s Technical Veterinary Advisor Renzo Di Florio as they revisit key insights from KRKA’s popular osteoarthritis podcast series.

This session will explore OA at different ages of a dog's life and will investigate how a deeper understanding of underlying pathology can support better long-term outcomes in dogs with OA, or at higher risk of this condition.

With a focus on early intervention and setting patients up for success from a young age, the speakers will share strategies for prevention, lifelong management, including the role of owner education, appropriate diagnostics, and a balanced approach to pain relief - from established options to newer therapies.
Expect concise, clinically relevant advice designed to help veterinary teams manage OA more effectively at every stage of the disease.

Register Now

00

DAYS

00

HOURS

00

MINS

00

SECS

REGISTER NOW

Enter your details below to be registered for the live event on Tuesday 30th September

What You'll Learn

Gain clear, practical insights into managing canine osteoarthritis. Explore how early diagnosis, owner engagement, and tailored treatment strategies can improve long-term outcomes for patients at every stage of the disease.

Canine Osteoarthritis Webinar

Learning Outcomes

  • Understand key pathological changes in canine osteoarthritis
  • Recognise the value of early diagnosis and intervention
  • Apply practical tools to create tailored management plans
  • Support long-term outcomes through owner engagement and pain management strategies
Register Now

Meet The Speakers

Join Professor Stuart Carmichael and Renzo Di Florio as they bring together clinical expertise and practical experience to explore new ways of diagnosing, treating, and managing canine osteoarthritis. 

About
KRKA

 

Krka partners closely with its customers to provide licensed medicines that are proven in clinical practice. With European-based manufacturing, the company ensures high-quality production standards, while its vertically integrated R&D and supply chain enable rapid response to market needs and consistent product availability. Supported by a dedicated sales team, Krka’s animal health portfolio includes well-established and effective treatments for both companion and food-producing animals. Key brands include Milprazon CHEWABLE®, Tolracol®, Robexera®, Cladaxxa®, and Otomicol®.

Visit KRKA